n-3 Fatty acid supplementation and proresolving mediators of inflammation
about
Clinical Benefits of n-3 PUFA and ɤ-Linolenic Acid in Patients with Rheumatoid Arthritis.Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodelingResolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.A cluster of immunoresolvents links coagulation to innate host defense in human blood.Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms.Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.Anti-inflammatory effects of an oxylipin-containing lyophilised biomass from a microalga in a murine recurrent colitis model.The role of specialized pro-resolving mediators in maternal-fetal health.A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men.Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review.Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.
P2860
Q33616563-919FB185-A4C7-4B7A-8AAF-75ECF43AFFDCQ34523903-14401BBA-CC7C-4B0F-927C-4BBE74227959Q37603197-E31E8FD0-E427-460D-A8B6-45908B6B8841Q38627502-22EA6A87-F297-4FBD-8A64-274DC7EF627DQ38647952-F84C0480-C7D8-489F-9246-2D672E9D91BEQ38658538-046B0C58-DEBC-4347-A3C8-AFDB1D121F64Q39088075-FA54856E-0F0F-4140-9553-403C6AF86FB6Q39197238-E30E4D1C-A05F-4D30-8BA0-059526DC6E2CQ40317977-DBB0C54C-1236-4479-AAD2-9FC1AF87CDA9Q46439903-1803665B-D93B-4A31-B7DF-E179AFF36E04Q46868692-6C027B1F-793C-431A-9157-F0A5D6C30447Q47947231-C69244AC-064F-4A83-847B-5D07FC89ACBBQ49266738-F18B28A3-6161-4CCD-B54A-31D74D86CF00Q52663243-52D7CB65-AFEA-492D-80CA-45821B8C50C8
P2860
n-3 Fatty acid supplementation and proresolving mediators of inflammation
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@ast
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@en
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@nl
type
label
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@ast
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@en
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@nl
prefLabel
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@ast
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@en
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@nl
P1476
n-3 Fatty acid supplementation and proresolving mediators of inflammation
@en
P2093
Anne E Barden
Emilie Mas
P356
10.1097/MOL.0000000000000262
P407
P577
2016-02-01T00:00:00Z